2016 was a big year for InnoGenomics, with the commercial release of our DNA testing kits, InnoTyper 21 and InnoQuant HY, that enable forensic DNA laboratories to successfully analyze challenging biological samples. The announcement garnered exposure in GenomeWeb and other media outlets, while fruitful collaborations with prominent members of the forensic science community such as the National Institute of Standards & Technology (NIST) and Netherlands Forensic Institute (NFI) generated data that demonstrated the utility of the kits, leading to presentations at international symposia in the U.S. and Australia, and publications in journals such as the International Journal of Legal Medicine. We also expanded our global distribution network in Asia and South America, and made significant strides in developing a cancer monitoring IVD blood test under our project funded by a National Cancer Institute (NCI) SBIR Phase I contract. Special thanks goes out to all our partners, clients, collaborators and friends. We couldn’t do this without you!